Clinical Trial Site

Copenhagen 2100

1 studies enrolling now · 4 studies all time

What they study most

ANCA-Associated Vasculitis, ATTR Amyloidosis, Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL), Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL), Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Transthyretin-Mediated Amyloidosis

Studies at this site

• ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) — Recruiting now
• A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. — Recruiting now
• APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) — Completed
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed